Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remodelling of miRNA Regulatory Landscape During West Nile Virus (WNV) Infection.

Epigenomes·2026
Same author

mRNA Vaccine Against Japanese Encephalitis Virus Genotype IV Protects Against Lethal Infection.

Viruses·2026
Same author

Evidence from COVID-19 Patients and Murine Studies for a Continuing Trend Towards Targeting of Nasopharyngeal Ciliated Epithelial Cells by SARS-CoV-2 Omicron Sublineages.

Viruses·2025
Same author

Tetravalent microprojection-based dengue chimeric virus vaccine raises potent neutralising antibodies in mice.

NPJ vaccines·2025
Same author

Author Correction: A single residue in the yellow fever virus envelope protein modulates virion architecture and antigenicity.

Nature communications·2025
Same author

Vaccine-Induced and Hybrid Immunity Against SARS-CoV-2 Variants of Concern in Two Cohorts in Queensland, Australia (2021-2022).

Journal of medical virology·2025

Related Experiment Video

Updated: May 12, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

16.8K

Insect-specific virus platforms for arbovirus vaccine development.

Roy A Hall1,2, Wilson Nguyen3, Alexander A Khromykh1,2

  • 1School of Chemistry and Molecular Biosciences, University of Queensland, St. Lucia, QLD, Australia.

Frontiers in Immunology
|March 31, 2025
PubMed
Summary

Insect-specific viruses (ISVs) are promising platforms for novel whole virus vaccines. Chimeric vaccines using these platforms show safety and efficacy in preclinical models, offering a new approach for disease prevention.

Keywords:
Aripo virusBinjari virusChaoyang virusEilat virusYN15-283-02 virusYada Yada virusarbovirusvaccine

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.8K
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

6.8K

Related Experiment Videos

Last Updated: May 12, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

16.8K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

21.8K
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

6.8K

Area of Science:

  • Virology
  • Vaccinology
  • Biotechnology

Background:

  • Insect-specific viruses (ISVs), including mosquito alphaviruses and orthoflaviviruses, are being explored as vaccine platforms.
  • These ISVs can accommodate structural polyproteins from pathogenic alphaviruses and orthoflaviviruses, creating chimeric viruses.

Purpose of the Study:

  • To review the progress of ISV-based chimeric vaccine technology.
  • To highlight the potential of ISVs for developing whole virus vaccines against human and veterinary pathogens.

Main Methods:

  • Development of chimeric vaccines by substituting ISV structural polyproteins with those from pathogenic viruses.
  • Evaluation of vaccine safety and efficacy in various animal models, including mice, non-human primates, crocodiles, and pigs.

Main Results:

  • ISV-based chimeric vaccines demonstrated safety and efficacy in preclinical evaluations.
  • These vaccines present authentic tertiary and quaternary whole virion structures, crucial for inducing protective antibody responses.
  • Vaccines are produced in mosquito cell lines (C6/36, C7-10) to high titers and do not replicate in vertebrate hosts.

Conclusions:

  • ISV-based chimeric vaccines represent a promising new strategy for whole virus vaccine development.
  • Further research is needed to address challenges in adjuvanting, manufacturing, and ensuring long-term safety.